Dr. Amjad Almahameed, MD, MPH

Dr. Almahameed practices at Novant Health Presbyterian Medical Center - Unit in Charlotte, North Carolina.

Dr. Almahameed's NPI, 1780793828, was assigned on August 30, 2006. Dr. Almahameed holds North Carolina license 2017-01661.

Dr. Almahameed's primary practice is Novant Health Presbyterian Medical Center - Unit, at 200 Hawthorne Lane Box 33549, Charlotte, NC 28233 in Mecklenburg County. The practice phone is (704) 384-4000.

Dr. Almahameed's primary practice is Novant Health Presbyterian Medical Center - Unit in Charlotte, North Carolina. Dr. Almahameed is also affiliated with Novant Health Presbyterian Medical Center. The medical group on file is Novant Health Indian Land Primary Care. Dmand AI also links Dr. Almahameed to 1 more hospital, 6 medical groups, 4 group practices and clinics and 1 behavioral health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Almahameed practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Almahameed's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Almahameed's licenses on file in 3 states: North Carolina, Louisiana and Ohio.

CMS data shows 521 Medicare services from Dr. Almahameed across 10 procedure codes in 2024, for 219 Medicare patients. Medicare paid $47,218 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 219 Medicare patients who saw Dr. Almahameed in 2024. The largest group is 75 to 84, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Almahameed's median patient age at 70, with 44% women.

In 2024, Dr. Almahameed wrote 1,728 Medicare Part D claims for 269 patients. 76% of them were for generic drugs. CMS names the drug for 1,632 of them, across 25 drugs with 11 or more claims each, at $338,580 in total drug cost. In 2023, CMS named 1,428 claims across 25 drugs.

Dr. Almahameed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 61 procedures of coronary angioplasty and stenting by Dr. Almahameed, more than 89% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Almahameed, published from 2019 to 2020. Dr. Almahameed's most frequent co-authors are Ehrin J. Armstrong, MD, Venita Chandra, MD and Bennett Cua, MD.

Dmand AI links Dr. Almahameed to 2 clinical trials. Conditions studied include Chronic Limb-Threatening Ischemia and Peripheral Arterial Disease. Open Payments lists research payments to Dr. Almahameed that name 1 trial.

CMS Open Payments shows 400 general payments to Dr. Almahameed from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 53% of the total. Edwards Lifesciences Corporation paid the most, $4,352. It also lists 1 research payment totaling $188 in 2016, naming 1 clinical trial.